-
<![CDATA[NCCN Update Supports MammaPrint to Guide Anthracycline Use in Breast Cancer]]>
20 Jan 2026 17:57 GMT
… anthracyclines, such as doxorubicin, in patients classified … that [H2] luminal breast cancer patients benefit from anthracycline … Oncology (NCCN Guidelines®). Breast Cancer. Version 1.2026. … presented at: San Antonio Breast Cancer Symposium; December 2025; …
-
CD44 Receptor-Mediated Delivery of ROS/pH Dual-Sensitive Nanoparticles Based on Poly(Ethylene Glycol)-b-Poly(Doxorubicin)-b-Hyaluronic Acid Copolymer
20 Jan 2026 06:05 GMT
… HA/Poly (Doxorubicin)/PEG Triblock Copolymer … was investigated using breast cancer cells in vitro … similar anticancer activities against breast cancer cells, PPDHA nanoparticles … polymeric anticancer drug Adriamycin-conjugated poly(ethylene glycol …
-
Lactate Dehydrogenase as a Potential Mediator Between Immature Granulocytes and Tumor Burden in Breast Cancer
16 Jan 2026 14:58 GMT
… breast cancer surgery;
Pathologically confirmed as the first and only primary malignant breast tumor … Among 778 Breast Cancer Participants
Collectively, … 39 Additionally, doxorubicin-induced neutrophil … interactions in breast cancer.
Nevertheless, …
-
Combinatorial Anti-Mitotic Activity of Loratadine/5-Fluorouracil Loaded Zein Tannic Acid Nanoparticles in Breast Cancer Therapy: In silico, in vitro and Cell Studies
15 Jan 2026 07:56 GMT
… are diagnosed with breast cancer. Breast cancer is considered to … therapeutic agent for breast cancer management.
Discussion
In … receptor-positive breast cancer. Int J Breast Cancer. 2013;2013 … of doxorubicin/metformin combination against breast cancer cell …
-
<![CDATA[Genomic Tools Highlight Genetic Differences Linked to More Aggressive Breast Cancer in Latin Women: William Audeh, MD, MS]]>
08 Jan 2026 00:32 GMT
… understanding of early breast cancer biology across diverse … for hormone-positive breast cancers. MammaPrint answers many … , whether anthracycline or adriamycin, one of the more … breast cancer, where we did see that they had more high-risk breast cancers …
-
Programmed Synergistic Photochemotherapy and Immune Activation of Triple Negative Breast Cancer Using Anti-PD-L1 Antibody-Conjugated Multifunctional Nanocapsules
07 Jan 2026 20:32 GMT
… Co., Ltd., China), doxorubicin hydrochloride (DOX) and … Triple negative breast cancer: pitfalls and progress. NPJ Breast Cancer. 2022 … and chemotherapy against breast tumors. Int J Nanomedicine … against triple-negative breast cancer through RIPK3-triggered …
-
Extracellular Vesicles as Emerging Drug Delivery Platforms in Triple-Negative Breast Cancer: A Systematic Review
07 Jan 2026 20:31 GMT
… for triple-negative breast cancer. Curr Breast Cancer Rep. 2021; … non-triple-negative breast cancer. Breast Cancer Res Treat. 2017 … to treat triple-negative breast cancers. Pharmaceutics. 2022; … for doxorubicin delivery to triple-negative breast cancer cells. …
-
Formulation and Physicochemical Characterization of Capecitabine-Loaded Cubosomes for Enhanced Drug Delivery System
20 Jan 2026 19:25 GMT
… advanced or metastatic breast cancer.11–14 After … and antimalarials on breast cancer cells. Biomolecules. … 5-Fluorouracil, and Doxorubicin using in silico approaches … monooleate-nanostructures containing doxorubicin hydrochloride. Pharmaceutics. …
-
Exploratory Research of Intraductal Chemotherapy to Control the Focal Breast Lesion of Breast Cancer
25 Dec 2025 13:59 GMT
… breast diseases.
Most breast cancers originate from the … malignant and benign breast tumors through detailed hemodynamic … chloroform to extract Adriamycin from tissue homogenate, … apolipoprotein a1-modified doxorubicin liposome for breast cancer treatment. Mol …
-
Synergistic Effects of Morin and Doxorubicin Overcome Chemoresistance in Ovarian Cancer: Preclinical Insights From in vitro and in vivo Models
07 Jan 2026 13:24 GMT
… in ovarian and breast cancers, particularly in models … doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer … pathway in human breast cancer MCF-7 cells. … death of BT474 breast cancer cells with autophagy …
About
© 1995-2026